BioSpace News Archive

Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of first-in-class therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted Orphan Drug Designation to zotiraciclib for the treatment of glioma.

Washington, D.C., Leads the Nation with Nearly 50% of E-Prescribers Utilizing the Technology

Nuvelution Pharma, Inc., announced that Ronald Martell, has been appointed as President and Chief Executive Officer. He will also serve on the Company’s Board of Directors.

Providing virtual access to nutrition services as part of the Teladoc Health comprehensive continuum of care will further optimize long-term health outcomes and ultimately reduce overall medical costs, particularly for those individuals with existing chronic and complicated health conditions.

WellCare Health Plans, Inc. announced the Kentucky Cabinet for Health and Family Services selected WellCare of Kentucky to continue serving the Commonwealth’s Medicaid managed care program in all eight program regions. The new five-year contract is anticipated to begin on July 1, 2020.

The Supreme Immune Health Formula™: The Immune System is the Answer to Disease

The offering is expected to result in gross proceeds to Therapix of $1,250,000.

Shineco, Inc. announced that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd., has entered into a 500,000 mu hemp fiber preliminary processing sales framework contract with Shanxi Oasis Textile Co., Ltd., one of the largest enterprises in China that produces textiles of hemp [and is the National Textile Industry Hemp Product Development Base.

AdventHealth Nicholson Center announces the official launch of its Prototype Lab to provide the technology, industry knowledge and testing needed to take a medical product from concept to working prototype.

Former UnitedHealth SVP of Oncology to Provide Strategic Guidance in Oncology Benefits Management